Is MFC a buy according to AI stock analysis?

MFC AI stock analysis does not label MFC as a universal buy because suitability depends on price, risk tolerance, time horizon, and portfolio context. The page views the business positively for diversification, Asia growth, core earnings, capital, dividends, and buybacks, but market, insurance, asset-management, currency, and valuation risks require a margin-of-safety discipline.

What is the MFC AI stock forecast?

The MFC AI stock forecast uses scenarios rather than a single prediction. The audited three-year framework produced a bullish zone near $62 to $68, a base zone near $43 to $49, and a bearish zone near $21 to $26 before dividends, with outcomes driven by earnings growth, Asia sales, CSM, claims, investment experience, Global WAM flows, capital, currency, and valuation multiples.

What technical levels matter for MFC?

The key MFC technical levels are near support around $40.00 to $40.50, broader support around $38.00 to $39.00, and resistance at the reported $41.70 52-week high. Refresh the 50-day and 200-day moving averages, RSI, and volume on a live chart because this static page does not present them as current trading signals.

Can AI predict MFC stock price?

No, AI cannot reliably predict stock prices. AI can organize filings, valuation math, technical levels, and risk scenarios, but MFC can move because of markets, interest rates, insurance claims, investment returns, policyholder behavior, asset-management flows, capital decisions, currency, earnings surprises, or market sentiment that no model can know in advance.

How should I use this MFC AI trading strategy?

Use this MFC AI trading strategy as a research checklist, not as personal financial advice. Confirm live prices, volume, moving averages, earnings dates, CSM, Asia sales, Global WAM flows, LICAT, market conditions, and management guidance before acting, and define invalidation levels before entering any trade.

What makes Manulife Financial different from other insurer stocks?

Manulife combines Canadian insurance, a high-growth Asia franchise, John Hancock in the United States, and global wealth and asset management. That diversification can support earnings resilience, but it also introduces market, insurance, flow, regulatory, currency, and execution risks that investors should monitor.

Manulife Financial Corporation research snapshot

MFC AI Stock Analysis

MFC AI stock analysis currently views Manulife Financial as a diversified insurer and wealth manager with an Asia growth franchise, Canadian scale, John Hancock operations in the United States, and global asset-management capabilities. At the July 11, 2026 data cutoff, the latest verified NYSE close was $41.09 on July 8 and market capitalization was about $68.62 billion. The score reflects strong core earnings, new-business momentum, a 136% LICAT ratio, and capital returns, while the MFC AI stock forecast remains scenario-based because investment markets, interest rates, insurance experience, asset-management flows, and currency can change results quickly. This page is for information only and is not investment advice.

Current price

$41.09

Market cap

$68.62 billion

AI score

70 / 100

Rating

Diversified life insurer and wealth manager with strong Asia growth and capital returns, balanced against market, insurance, and flow risk

Trend status

Positive price trend near the 52-week high, with a live-chart refresh needed for moving-average confirmation

Data cutoff (updated weekly)

July 11, 2026

Informational use only. This page is not investment advice.

Research quality check

information Richness: A-level information richness. Manulife has audited reports, quarterly disclosures, capital disclosures, detailed segment reporting, liquid listings, and broad third-party coverage.
bias Check: The main AI bias risk is extrapolating Asia growth, higher core EPS, dividends, and buybacks while under-weighting market-sensitive earnings, alternative-asset performance, insurance claims, Global WAM net outflows, regulatory capital, and foreign-exchange effects.
ai Confidence: High for FY2025 and Q1 2026 disclosures, market-cap arithmetic, and the stated valuation inputs. Medium for forward value because insurance accounting, investment returns, claims, rates, and client flows can change quickly.
investment Certainty: Medium. The businesses are well disclosed and diversified, but underwriting the shares requires a view on capital markets, Asia execution, insurance experience, asset-management flows, and the valuation paid for those earnings.

Quick verdict table

Dimension	Conclusion	Confidence
Business quality	Manulife earns from life and health insurance, annuities, retirement products, wealth and asset management, banking, and investment products across Asia, Canada, the United States, and global institutional channels.	High
Moat	The moat rests on trusted brands, insurance licenses, distribution relationships, actuarial and investment capabilities, long-duration policyholder relationships, scale, data, and regulatory infrastructure.	Medium-high
Management	CEO Phil Witherington and the leadership team must convert Asia and Global WAM growth into durable earnings while keeping underwriting, investment, expense, capital, and acquisition discipline intact.	Medium
Financial trend	FY2025 core earnings were C$7.521 billion and net income attributed to shareholders was C$5.572 billion. Q1 2026 core earnings were C$1.836 billion, up 8% on a constant-exchange-rate basis, while new business CSM rose 16%.	High
Valuation	Using the July 8 close of $41.09, $2.49 trailing EPS, $21.00 book value per share, and $1.33 annual dividend, financial_rigor.py calculates 16.50x earnings, 1.96x book value, and a 3.24% dividend yield.	High
Technical trend	The July 8 close was close to the reported 52-week high of $41.70. That is constructive momentum, but it also increases breakout-failure risk and needs refreshed moving averages, RSI, and volume before a trade.	Medium
Risk level	Key risks include investment-market and interest-rate moves, alternative-asset returns, mortality and morbidity claims, lapse behavior, Global WAM flows, capital requirements, currency, execution in Asia, and valuation compression.	Medium-high
AI confidence	Historical filings and reproducible calculations have high confidence. Forecast confidence is lower because no model can know future markets, insurance experience, policyholder behavior, or valuation multiples.	High data confidence
Investment certainty	MFC is not an automatic buy at this price. Durable upside needs continued Asia growth, resilient core earnings, controlled claims and investment experience, stronger WAM flows, capital discipline, and a reasonable valuation.	Medium

MFC AI stock forecast

MFC AI Stock Forecast Scenarios

The MFC AI stock forecast uses the $41.09 July 8 NYSE close and $2.49 trailing EPS in a three-year scenario calculation audited with financial_rigor.py. It produces bearish, base, and bullish values near $23.50, $46.10, and $66.30 before dividends. These ranges are not price promises.

Bullish case

$62 to $68

More likely if EPS compounds near 10%, Asia insurance sales and CSM growth remain strong, Global WAM flows improve, claims and investment experience are favorable, capital stays strong, and investors pay about 20x earnings.

Base case

$43 to $49

More likely if EPS grows near 5%, Asia and wealth-management gains offset normal market and insurance variability, dividends and buybacks continue, and the market values MFC near 16x earnings.

Bearish case

$21 to $26

More likely if investment markets or alternative assets weaken, claims or lapse experience deteriorates, Global WAM outflows persist, Asia growth slows, capital becomes constrained, or the multiple contracts toward 11x lower earnings.

MFC AI technical analysis

MFC AI Technical Analysis

MFC AI technical analysis uses the latest available July 8, 2026 market snapshot. The NYSE close was $41.09, the reported 52-week range was $29.70 to $41.70, and daily volume was 1.03 million shares. The source gap is that a dated 50-day average, 200-day average, and RSI were not independently available in the static research inputs, so a live chart must supply them before trading.

Level	Value	Why it matters
Current price	$41.09	NYSE close on July 8, 2026, used for the market-cap and valuation calculations.
Near support	$40.00 to $40.50	The recent breakout area is a first price reference, not a guaranteed support level.
Secondary support	$38.00 to $39.00	Use a refreshed 50-day moving average and price structure to reassess this zone.
Near resistance	$41.70	Reported 52-week high in the July 8 market snapshot.
Moving averages	Refresh on a live chart	Confirm price versus live 50-day and 200-day averages before treating the trend as actionable.
Momentum	Near 52-week high	Momentum is constructive, but a new high alone does not confirm a durable trend.
Volume	1.03 million shares	July 8 daily volume. A move through $41.70 is more credible when live volume exceeds recent averages.
Volatility	5-year beta 0.78	Reported beta is moderate, but earnings, interest rates, claims, markets, and currency can move an insurer sharply.
Invalidation	Sustained close below $40, then $38	A failed hold of nearby support weakens the short-term setup. Recheck moving averages before using a wider stop.

MFC AI trading strategy

MFC AI Trading Strategy Framework

The MFC AI trading strategy is a rules-based research framework, not personal financial advice. It combines live price and volume behavior with quarterly core earnings, new-business CSM, Asia sales, Global WAM flows, LICAT capital, book value, market and rate conditions, claims experience, and management guidance.

Trend-following setup

Watch whether MFC holds the $40.00 to $40.50 area and clears $41.70 on above-average live volume, while results confirm core-earnings growth, insurance sales, CSM growth, capital strength, and controlled market experience.

A breakout that fails below $40 should reduce trend confidence, especially if results show weaker Asia growth, asset-management flows, investment returns, or capital.

Mean-reversion setup

If MFC retraces toward $38 to $40 without a deterioration in core earnings, claims, CSM, LICAT, or asset-management flows, compare the updated price with book value, sustainable EPS, dividend policy, buybacks, and investment-market conditions.

Do not assume a lower insurer share price is value when capital markets, alternative-asset marks, claims, lapses, or capital requirements are worsening.

Fundamental monitor

Track core earnings and EPS, net income, core ROE, LICAT, book value, new business CSM, APE sales, Asia and Global WAM segment trends, net flows, remittances, dividends, buybacks, and the next earnings release.

Position sizing should reflect financial-market sensitivity, long-duration insurance liabilities, foreign exchange, regulation, and the possibility that reported earnings differ from core earnings.

Investment research summary

Four-master Research Compression

Business essence

Customers pay Manulife to protect income and health risks, save for retirement, invest assets, obtain wealth advice, manage benefits, and access banking and retirement products. The company earns fees, insurance margins, and investment income across Asia, Canada, the United States, and institutional asset management.

Moat

Manulife has regulated licenses, brands including Manulife and John Hancock, distribution relationships, policyholder trust, actuarial and investment capabilities, long-lived customer relationships, data, and scale. These advantages are meaningful but do not remove price competition, regulation, investment risk, or lapse risk.

Munger risk inversion

The thesis can fail if markets or alternative assets underperform, claims rise, policyholder lapse behavior changes, Asia growth slows, Global WAM outflows persist, capital requirements rise, acquisitions disappoint, cyber or conduct events damage trust, or foreign exchange reduces reported results.

Management

Phil Witherington and the leadership team are responsible for growth in insurance and wealth, disciplined expense and capital allocation, underwriting and investment controls, distribution productivity, and shareholder returns. The test is sustained value creation through a full market and insurance cycle, not one strong quarter.

Industry trend

Ageing populations, retirement savings, protection needs, health and longevity products, and Asian wealth growth are durable demand drivers. Insurance and asset management remain regulated, competitive, capital intensive, and exposed to markets, rates, claims, and client flows.

Valuation and margin of safety

At 16.50x trailing EPS and 1.96x book value per share, MFC is not priced as a distressed insurer. Margin of safety improves if price falls while core earnings, capital, claims, investment quality, CSM growth, and distributions remain intact.

Source-backed data

MFC Data Table

Every metric below includes a source and last verification date.

Metric	Value	Source	Last verified
MFC price and market capitalization	$41.09 NYSE close on July 8, 2026. Applying the 1.67 billion reported shares gives $68.62 billion, matching the market-cap arithmetic input.	StockAnalysis MFC overview, statistics, and history; Pineify financial_rigor.py	July 11, 2026
Shares outstanding	1.67 billion shares outstanding, down 3.91% year over year in the July 8 market-data snapshot.	StockAnalysis MFC statistics	July 11, 2026
FY2025 earnings and capital return	C$7.521 billion core earnings, C$5.572 billion net income attributable to shareholders, C$4.21 core EPS, C$3.07 EPS, 16.5% core ROE, 136% LICAT, 54.4 million shares repurchased and cancelled, and a 10.2% dividend increase.	Manulife FY2025 results and annual report, cross-checked with StockAnalysis after currency translation	July 11, 2026
Q1 2026 results	C$1.836 billion core earnings, C$1.147 billion net income attributable to shareholders, C$1.06 core EPS, C$0.65 EPS, 16.5% core ROE, 136% LICAT, C$1.019 billion new business CSM, and C$4.4 billion Global WAM net outflows.	Manulife Q1 2026 press release	July 11, 2026
Cash and debt	$21.69 billion cash and cash equivalents, $16.83 billion total debt, and $1.07 billion net cash in the independent market-data presentation. For an insurer, these headline figures do not by themselves measure liquidity or capital adequacy.	StockAnalysis MFC statistics, cross-checked to Manulife annual-report balance-sheet disclosures after currency translation	July 11, 2026
Valuation inputs	$2.49 trailing EPS, $21.00 book value per share, $1.33 annual dividend, 16.50x calculated trailing PE, 1.96x calculated price-to-book, and 3.24% calculated dividend yield.	StockAnalysis MFC statistics and Pineify financial_rigor.py	July 11, 2026
Source limitation	IFRS 17 insurance revenue is not reliably comparable across the available aggregators. Macrotrends displayed a zero FY2025 revenue value while reporting a positive Q1 2026 figure, so this page relies on Manulife earnings, CSM, capital, and segment disclosures instead of presenting a false revenue cross-check. Dated moving averages and RSI were also unavailable in the static source set.	Macrotrends MFC revenue page; Manulife filings; StockAnalysis	July 11, 2026

Frequently Asked Questions

Compare MET AI stock analysis Read BMO AI stock forecast Explore TD AI technical analysis Open Pineify AI Stock Picker Build an AI trading strategy

This MFC AI stock analysis page is an informational research tool only. It is not investment advice, financial planning, a recommendation, or a guarantee of future performance. Forecast scenarios are based on available public data and simplified assumptions as of the stated cutoff date, and they may be wrong.